{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:35:32Z","timestamp":1760646932935},"reference-count":286,"publisher":"Elsevier","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.apcsb.2018.09.004","type":"book-chapter","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T15:18:53Z","timestamp":1543418333000},"page":"153-219","source":"Crossref","is-referenced-by-count":12,"title":["Inflammatory response and its relation to sphingolipid metabolism proteins: Chaperones as potential indirect anti-inflammatory agents"],"prefix":"10.1016","author":[{"given":"Z. Begum","family":"Yagci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Esvap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice Asuman","family":"Ozkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kutlu O.","family":"Ulgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif Ozkirimli","family":"Olmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.apcsb.2018.09.004_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3827684","article-title":"Fostering inflammatory bowel disease: Sphingolipid strategies to join forces","volume":"2016","author":"Abdel Hadi","year":"2016","journal-title":"Mediators of Inflammation"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb0015","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1021\/mp200313e","article-title":"Therapeutic strategies for Gaucher disease: Miglustat (NB-DNJ) as a pharmacological chaperone for glucocerebrosidase and the different thermostability of velaglucerase alfa and imiglucerase","volume":"8","author":"Abian","year":"2011","journal-title":"Molecular Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/acel.12409","article-title":"Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages","volume":"15","author":"Aflaki","year":"2016","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neuron.2017.01.018","article-title":"The complicated relationship between Gaucher disease and parkinsonism: Insights from a rare disease","volume":"93","author":"Aflaki","year":"2017","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0030","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.12669\/pjms.334.12975","article-title":"Ethical issues in managing lysosomal storage disorders in children in low and middle income countries","volume":"33","author":"Afroze","year":"2017","journal-title":"Pakistan Journal of Medical Sciences"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4239\/wjd.v5.i5.697","article-title":"Targeting inflammation in diabetes: Newer therapeutic options","volume":"5","author":"Agrawal","year":"2014","journal-title":"World Journal of Diabetes"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-\u03b3: Receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb0045","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/emmm.201202301","article-title":"Systemic ceramide accumulation leads to severe and varied pathological consequences","volume":"5","author":"Alayoubi","year":"2013","journal-title":"EMBO Molecular Medicine"},{"issue":"8","key":"10.1016\/bs.apcsb.2018.09.004_bb0050","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cbic.201200708","article-title":"Bicyclic derivatives of l-idonojirimycin as pharmacological chaperones for neuronopathic forms of Gaucher disease","volume":"14","author":"Alfonso","year":"2013","journal-title":"Chembiochem"},{"issue":"9","key":"10.1016\/bs.apcsb.2018.09.004_bb0055","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1074\/jbc.M110.171819","article-title":"Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking","volume":"286","author":"Allende","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0060","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/816593","article-title":"Recent advances in the diagnosis and treatment of Niemann-Pick disease type C in children: A guide to early diagnosis for the general pediatrician","volume":"2015","author":"Alobaidy","year":"2015","journal-title":"International Journal of Pediatrics"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.09.004_bb0065","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1134\/S0006297914070049","article-title":"Secondary biochemical and morphological consequences in lysosomal storage diseases","volume":"79","author":"Alroy","year":"2014","journal-title":"Biochemistry (Moscow)"},{"issue":"7301","key":"10.1016\/bs.apcsb.2018.09.004_bb0070","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nature09128","article-title":"Sphingosine-1-phosphate: A missing cofactor for the E3 ubiquitin ligase TRAF2","volume":"465","author":"Alvarez","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1017\/S001216220600082X","article-title":"Atypical clinical course in juvenile metachromatic leukodystrophy involving novel arylsulfatase A gene mutations","volume":"48","author":"Anlar","year":"2006","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0080","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader","year":"2003","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0085","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.4049\/jimmunol.1000644","article-title":"Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-\u03b1-induced arthritis","volume":"185","author":"Baker","year":"2010","journal-title":"The Journal of Immunology"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.09.004_bb0090","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2174\/13894501113149990158","article-title":"Leukocyte traffic blockade in inflammatory bowel disease","volume":"14","author":"Bamias","year":"2013","journal-title":"Current Drug Targets"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.09.004_bb0095","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1515\/hsz-2013-0219","article-title":"Molecular triggers of neuroinflammation in mouse models of demyelinating diseases","volume":"394","author":"Barrette","year":"2013","journal-title":"Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1172\/JCI34431","article-title":"A calculated response: Control of inflammation by the innate immune system","volume":"118","author":"Barton","year":"2008","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb0105","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/cge.12316","article-title":"Molecular analyses of novel ASAH1 mutations causing Farber lipogranulomatosis: Analyses of exonic splicing enhancer inactivating mutation","volume":"86","author":"Bashyam","year":"2013","journal-title":"Clinical Genetics"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb0110","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1183\/09031936.00080014","article-title":"Ceramide-1-phosphate inhibits cigarette smoke-induced airway inflammation","volume":"45","author":"Baudi\u00df","year":"2015","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0115","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0014-4886(03)00345-5","article-title":"Postnatal development of inflammation in a murine model of Niemann\u2013Pick type C disease: Immunohistochemical observations of microglia and astroglia","volume":"184","author":"Baudry","year":"2003","journal-title":"Experimental Neurology"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0120","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/gim.2016.122","article-title":"The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat","volume":"19","author":"Benjamin","year":"2017","journal-title":"Genetics in Medicine"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0125","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/mt.2011.271","article-title":"Co-administration with the pharmacological chaperone AT1001 increases recombinant human \u03b1-galactosidase A tissue uptake and improves substrate reduction in Fabry mice","volume":"20","author":"Benjamin","year":"2012","journal-title":"Molecular Therapy"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0130","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ymgme.2014.05.009","article-title":"Pharmacological chaperones increase residual \u03b2-galactocerebrosidase activity in fibroblasts from Krabbe patients","volume":"112","author":"Berardi","year":"2014","journal-title":"Molecular Genetics and Metabolism"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.09.004_bb0135","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3181\/0901-MR-12","article-title":"The epidermal growth factor receptor: A link between inflammation and liver cancer","volume":"234","author":"Berasain","year":"2009","journal-title":"Experimental Biology and Medicine (Maywood, NJ)"},{"issue":"11","key":"10.1016\/bs.apcsb.2018.09.004_bb0140","doi-asserted-by":"crossref","first-page":"931","DOI":"10.18632\/aging.100702","article-title":"Loss of Nfkb1 leads to early onset aging","volume":"6","author":"Bernal","year":"2014","journal-title":"Aging (Albany, NY)"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0010021","article-title":"Enzyme replacement in Gaucher disease","volume":"1","author":"Beutler","year":"2004","journal-title":"PLoS Medicine"},{"issue":"417","key":"10.1016\/bs.apcsb.2018.09.004_bb0150","article-title":"Neuroinflammatory paradigms in lysosomal storage diseases","volume":"9","author":"Bosch","year":"2015","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0155","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajhg.2013.05.006","article-title":"Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia","volume":"93","author":"Boukhris","year":"2013","journal-title":"American Journal of Human Genetics"},{"issue":"11","key":"10.1016\/bs.apcsb.2018.09.004_bb0160","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nature Reviews Drug Discovery"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ymgme.2008.04.012","article-title":"GM1 gangliosidosis: Review of clinical, molecular, and therapeutic aspects","volume":"94","author":"Brunetti-Pierri","year":"2008","journal-title":"Molecular Genetics and Metabolism"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb0170","doi-asserted-by":"crossref","first-page":"1505S","DOI":"10.1093\/ajcn\/83.6.1505S","article-title":"n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases","volume":"83","author":"Calder","year":"2006","journal-title":"The American Journal of Clinical Nutrition"},{"issue":"7\u20138","key":"10.1016\/bs.apcsb.2018.09.004_bb0175","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.clinbiochem.2011.12.019","article-title":"Four novel mutations in the \u03b2-galactosidase gene identified in infantile type of GM1 gangliosidosis","volume":"45","author":"\u00c7eltik\u00e7i","year":"2012","journal-title":"Clinical Biochemistry"},{"issue":"10\u201311","key":"10.1016\/bs.apcsb.2018.09.004_bb0180","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.clinbiochem.2011.04.022","article-title":"Two novel alpha-galactosidase A mutations causing Fabry disease: A missense mutation M11V in a heterozygote woman and a nonsense mutation R190X in a hemizygote man","volume":"44","author":"Celtikci","year":"2011","journal-title":"Clinical Biochemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0185","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/humu.22919","article-title":"Mutation update of ARSA and PSAP genes causing metachromatic leukodystrophy","volume":"37","author":"Cesani","year":"2016","journal-title":"Human Mutation"},{"issue":"Database Issue","key":"10.1016\/bs.apcsb.2018.09.004_bb0190","doi-asserted-by":"crossref","first-page":"D369","DOI":"10.1093\/nar\/gkw1102","article-title":"The BioGRID interaction database: 2017 update","volume":"45","author":"Chatr-Aryamontri","year":"2017","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0195","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.survophthal.2013.02.005","article-title":"Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders","volume":"59","author":"Chen","year":"2014","journal-title":"Survey of Ophthalmology"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0200","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12035-013-8605-5","article-title":"Chaperone therapy for GM2 gangliosidosis: Effects of pyrimethamine on \u03b2-hexosaminidase activity in Sandhoff fibroblasts","volume":"50","author":"Chiricozzi","year":"2014","journal-title":"Molecular Neurobiology"},{"issue":"10","key":"10.1016\/bs.apcsb.2018.09.004_bb0205","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1172\/JCI90609","article-title":"CNS inflammation and neurodegeneration","volume":"127","author":"Chitnis","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"issue":"38","key":"10.1016\/bs.apcsb.2018.09.004_bb0210","article-title":"Bioactive lipids and chronic inflammation: Managing the fire within","volume":"9","author":"Chiurchi\u00f9","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"86","key":"10.1016\/bs.apcsb.2018.09.004_bb0215","article-title":"FTY720 attenuates excitotoxicity and neuroinflammation","volume":"12","author":"Cipriani","year":"2015","journal-title":"Journal of Neuroinflammation"},{"issue":"10","key":"10.1016\/bs.apcsb.2018.09.004_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165463","article-title":"Identification of an allosteric binding site on human lysosomal alpha-galactosidase opens the way to new pharmacological chaperones for Fabry disease","volume":"11","author":"Citro","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0225","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2010.09.004","article-title":"An open-label phase I\/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay\u2013Sachs or Sandhoff variants)","volume":"102","author":"Clarke","year":"2011","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0230","unstructured":"ClinicalTrials.gov. (2013a). NCT01802970. Safety and blood immune cell study of Anakinra plus Physician's chemotherapy choice in metastatic breast cancer patients. Retrieved August 10, 2018, from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01802970"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0235","unstructured":"ClinicalTrials.gov. (2013b). NCT02021422. A pilot, prospective, non-randomized evaluation of the safety of Anakinra plus standard chemotherapy. Retrieved August 10, 2018, from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02021422"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0240","unstructured":"ClinicalTrials.gov. (2014). NCT02090101. Study evaluating the influence of LV5FU2 bevacizumab plus Anakinra association on metastatic colorectal Cancer (IRAFU). Retrieved August 10, 2018, from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02090101"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0245","unstructured":"ClinicalTrials.gov. (2018). NCT03588936. Nivolumab and tocilizumab for relapsed hematological malignancy post-allogeneic transplant. Retrieved August 22, 2018, from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03588936"},{"issue":"24","key":"10.1016\/bs.apcsb.2018.09.004_bb0250","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1093\/bioinformatics\/btt547","article-title":"BioServices: A common Python package to access biological web services programmatically","volume":"29","author":"Cokelaer","year":"2013","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb0255","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1021\/acschembio.6b00195","article-title":"Pharmacological chaperones: Design and development of new therapeutic strategies for the treatment of conformational diseases","volume":"11","author":"Convertino","year":"2016","journal-title":"ACS Chemical Biology"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0260","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/path.3021","article-title":"The cellular pathology of lysosomal diseases","volume":"226","author":"Cox","year":"2012","journal-title":"The Journal of Pathology"},{"issue":"Suppl. 3","key":"10.1016\/bs.apcsb.2018.09.004_bb0265","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar4174","article-title":"Use of NSAIDs in treating patients with arthritis","volume":"15","author":"Crofford","year":"2013","journal-title":"Arthritis Research & Therapy"},{"issue":"8","key":"10.1016\/bs.apcsb.2018.09.004_bb0270","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.bbalip.2012.01.003","article-title":"Connecting vesicular transport with lipid synthesis: FAPP2","volume":"1821","author":"D\u2019Angelo","year":"2012","journal-title":"Biochimica et Biophysica Acta"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb0275","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.molmet.2013.05.006","article-title":"The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis","volume":"2","author":"Davis","year":"2013","journal-title":"Molecular Metabolism"},{"issue":"37","key":"10.1016\/bs.apcsb.2018.09.004_bb0280","doi-asserted-by":"crossref","first-page":"15169","DOI":"10.1073\/pnas.1105639108","article-title":"Insights into Krabbe disease from structures of galactocerebrosidase","volume":"108","author":"Deane","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10903","key":"10.1016\/bs.apcsb.2018.09.004_bb0285","article-title":"Pharmacological chaperones and coenzyme Q10 treatment improves mutant \u03b2-glucocerebrosidase activity and mitochondrial function in neuronopathic forms of Gaucher disease","volume":"5","author":"de la Mata","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0290","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jmgm.2015.11.004","article-title":"A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors","volume":"63","author":"Deniz","year":"2016","journal-title":"Journal of Molecular Graphics and Modelling"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb0295","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): An overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"Journal of Interferon & Cytokine Research"},{"issue":"8","key":"10.1016\/bs.apcsb.2018.09.004_bb0300","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"8","key":"10.1016\/bs.apcsb.2018.09.004_bb0305","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2014.02.012","article-title":"Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease","volume":"35","author":"Dinkins","year":"2014","journal-title":"Neurobiology of Aging"},{"issue":"33","key":"10.1016\/bs.apcsb.2018.09.004_bb0310","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1523\/JNEUROSCI.1429-16.2016","article-title":"Neutral sphingomyelinase-2 deficiency ameliorates Alzheimer's disease pathology and improves cognition in the 5XFAD mouse","volume":"36","author":"Dinkins","year":"2016","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0315","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1546-0096-5-15","article-title":"Farber disease: Clinical presentation, pathogenesis and a new approach to treatment","volume":"5","author":"Ehlert","year":"2007","journal-title":"Pediatric Rheumatology Online Journal"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0320","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jbior.2016.11.001","article-title":"Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis","volume":"63","author":"Espaillat","year":"2017","journal-title":"Advances in Biological Regulation"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.09.004_bb0325","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/hmg\/ddr019","article-title":"Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease","volume":"20","author":"Farfel-Becker","year":"2011","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0330","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2018.02.021","article-title":"Functional and pharmacological evaluation of novel GLA variants in Fabry disease identifies six (two de novo) causative mutations and two amenable variants to the chaperone DGJ","volume":"481","author":"Ferri","year":"2018","journal-title":"Clinica Chimica Acta"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb0335","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1165\/rcmb.2009-0422OC","article-title":"Neutral sphingomyelinase 2: A novel target in cigarette smoke-induced apoptosis and lung injury","volume":"44","author":"Filosto","year":"2011","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0340","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2016.09.095","article-title":"(5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal \u03b2-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B","volume":"126","author":"Front","year":"2017","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0345","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1096\/fj.201601156R","article-title":"Ceramides and mitochondrial fatty acid oxidation in obesity","volume":"31","author":"Fucho","year":"2016","journal-title":"The FASEB Journal"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.09.004_bb0350","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.bmcl.2017.04.062","article-title":"Phenanthridin-6-one derivatives as the first class of non-steroidal pharmacological chaperones for Niemann-Pick disease type C1 protein","volume":"27","author":"Fukuda","year":"2017","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb0355","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1021\/acs.jmedchem.6b01550","article-title":"Fluorinated chaperone-\u03b2-cyclodextrin formulations for \u03b2-glucocerebrosidase activity enhancement in neuronopathic Gaucher disease","volume":"60","author":"Garc\u00eda-Moreno","year":"2017","journal-title":"Journal of Medicinal Chemistry"},{"issue":"13","key":"10.1016\/bs.apcsb.2018.09.004_bb0360","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1074\/jbc.M708735200","article-title":"Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding","volume":"283","author":"Gelsthorpe","year":"2008","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0365","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1194\/jlr.E500002-JLR200","article-title":"Bridging the innate and adaptive immune systems","volume":"46","author":"Getz","year":"2005","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0370","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/487508","article-title":"Role of sphingolipids in the pathobiology of lung inflammation","volume":"2015","author":"Ghidoni","year":"2015","journal-title":"Mediators of Inflammation"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.09.004_bb0375","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","article-title":"Parkinsonism among Gaucher disease carriers","volume":"41","author":"Goker-Alpan","year":"2004","journal-title":"Journal of Medical Genetics"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0380","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2567.2008.02928.x","article-title":"A ceramide-1-phosphate analogue, PCERA-1, simultaneously suppresses tumour necrosis factor-\u03b1 and induces interleukin-10 production in activated macrophages","volume":"127","author":"Goldsmith","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0385","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.plipres.2015.09.002","article-title":"Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate","volume":"61","author":"Gomez-Mu\u00f1oz","year":"2016","journal-title":"Progress in Lipid Research"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb0390","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1074\/jbc.M510434200","article-title":"Rac1 modulates sphingosine 1-phosphate-mediated activation of phosphoinositide 3-kinase\/Akt signaling pathways in vascular endothelial cells","volume":"281","author":"Gonzalez","year":"2006","journal-title":"Journal of Biological Chemistry"},{"issue":"13","key":"10.1016\/bs.apcsb.2018.09.004_bb0395","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1074\/jbc.M115.691212","article-title":"Ceramide synthase 5 is essential to maintain C16:0-ceramide pools and contributes to the development of diet-induced obesity","volume":"291","author":"Gosejacob","year":"2016","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0400","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/1947-2714.94944","article-title":"Evaluation of TNF-\u03b1 and IL-6 levels in obese and non-obese diabetics: Pre- and postinsulin effects","volume":"4","author":"Goyal","year":"2012","journal-title":"North American Journal of Medical Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0405","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000362983","article-title":"Regulation of the inflammasome by ceramide in cystic fibrosis lungs","volume":"34","author":"Grassm\u00e9","year":"2014","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0410","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nm823","article-title":"Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts","volume":"9","author":"Grassm\u00e9","year":"2003","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0415","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2014.09.046","article-title":"History, genetic, and recent advances on Krabbe disease","volume":"555","author":"Graziano","year":"2015","journal-title":"Gene"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.09.004_bb0420","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.chembiol.2011.10.012","article-title":"The molecular basis of pharmacological chaperoning in human \u03b1-galactosidase","volume":"18","author":"Guce","year":"2011","journal-title":"Chemistry & Biology"},{"issue":"3\u20134","key":"10.1016\/bs.apcsb.2018.09.004_bb0425","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.prostaglandins.2007.11.002","article-title":"Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages","volume":"85","author":"Hammad","year":"2008","journal-title":"Prostaglandins & Other Lipid Mediators"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb0430","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.bbalip.2013.06.006","article-title":"Co-evolution of sphingomyelin and the ceramide transport protein CERT","volume":"1841","author":"Hanada","year":"2014","journal-title":"Biochimica et Biophysica Acta"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0435","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: Lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb0440","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.09.004_bb0445","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/brain\/awt270","article-title":"Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis","volume":"136","author":"Harlalka","year":"2013","journal-title":"Brain"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.09.004_bb0450","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/humu.21516","article-title":"Chemical chaperone therapy: Chaperone effect on mutant enzyme and cellular pathophysiology in \u03b2-galactosidase deficiency","volume":"32","author":"Higaki","year":"2011","journal-title":"Human Mutation"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb0455","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1039\/C5SC00754B","article-title":"Azasugar inhibitors as pharmacological chaperones for Krabbe disease","volume":"6","author":"Hill","year":"2015","journal-title":"Chemical Science"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0460","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10545-014-9718-3","article-title":"Treatment of lysosomal storage disorders: Successes and challenges","volume":"37","author":"Hollak","year":"2014","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"Suppl. 1","key":"10.1016\/bs.apcsb.2018.09.004_bb0465","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.5213\/inj.1632604.302","article-title":"Pathophysiological role of neuroinflammation in neurodegenerative diseases and psychiatric disorders","volume":"20","author":"Hong","year":"2016","journal-title":"International Neurourology Journal"},{"issue":"9","key":"10.1016\/bs.apcsb.2018.09.004_bb0470","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/jhg.2015.61","article-title":"Chaperone therapy for Krabbe disease: Potential for late-onset GALC mutations","volume":"60","author":"Hossain","year":"2015","journal-title":"Journal of Human Genetics"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb0475","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/jcb.21563","article-title":"Sphingosine 1-phosphate induces EGFR expression via Akt\/NF-kappaB and ERK\/AP-1 pathways in rat vascular smooth muscle cells","volume":"103","author":"Hsieh","year":"2008","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0480","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/830490","article-title":"Pharmacological chaperone design for reducing risk factor of Parkinson's disease from traditional Chinese medicine","volume":"2014","author":"Huang","year":"2014","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"issue":"11","key":"10.1016\/bs.apcsb.2018.09.004_bb0485","doi-asserted-by":"crossref","DOI":"10.1038\/oby.2011.107","article-title":"Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients","volume":"19","author":"Huang","year":"2011","journal-title":"Obesity (Silver Spring, Md.)"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0490","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jmedgenet-2016-104178","article-title":"Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-Month results from the randomised phase III ATTRACT study","volume":"54","author":"Hughes","year":"2017","journal-title":"Journal of Medical Genetics"},{"issue":"13","key":"10.1016\/bs.apcsb.2018.09.004_bb0495","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1021\/ja973443k","article-title":"1-N-Iminosugars: Potent and selective inhibitors of \u03b2-glycosidases","volume":"120","author":"Ichikawa","year":"1998","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0500","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-0500-7-11","article-title":"De novo mutation in a male patient with Fabry disease: A case report","volume":"7","author":"Iemolo","year":"2014","journal-title":"BMC Research Notes"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0505","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2183\/pjab.88.18","article-title":"Pharmacological chaperone therapy for Fabry disease","volume":"88","author":"ISHII","year":"2012","journal-title":"Proceedings of the Japan Academy. Series B, Physical and Biological Sciences"},{"issue":"5963","key":"10.1016\/bs.apcsb.2018.09.004_bb0510","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.1183021","article-title":"Regulation of adaptive immunity by the innate immune system","volume":"327","author":"Iwasaki","year":"2010","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0515","series-title":"Immunobiology: The immune system in health and disease","article-title":"The components of the immune system","author":"Janeway","year":"2001"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb0520","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ana.20242","article-title":"NSAIDs increase survival in the Sandhoff disease mouse: Synergy with N-butyldeoxynojirimycin","volume":"56","author":"Jeyakumar","year":"2004","journal-title":"Annals of Neurology"},{"issue":"Pt 4","key":"10.1016\/bs.apcsb.2018.09.004_bb0525","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/brain\/awg089","article-title":"Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis","volume":"126","author":"Jeyakumar","year":"2003","journal-title":"Brain"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0530","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6930","article-title":"Proinflammatory TLR signalling is regulated by a TRAF2-dependent proteolysis mechanism in macrophages","volume":"6","author":"Jin","year":"2015","journal-title":"Nature Communications"},{"issue":"Database Issue","key":"10.1016\/bs.apcsb.2018.09.004_bb0535","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","article-title":"KEGG as a reference resource for gene and protein annotation","volume":"44","author":"Kanehisa","year":"2016","journal-title":"Nucleic Acids Research"},{"issue":"Database issue","key":"10.1016\/bs.apcsb.2018.09.004_bb0540","doi-asserted-by":"crossref","first-page":"D767","DOI":"10.1093\/nar\/gkn892","article-title":"Human protein reference database\u20142009 update","volume":"37","author":"Keshava Prasad","year":"2009","journal-title":"Nucleic Acids Research"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0545","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/CIRCRESAHA.115.306427","article-title":"Adaptive response of T and B cells in atherosclerosis","volume":"118","author":"Ketelhuth","year":"2016","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0550","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/mt.2009.220","article-title":"The pharmacological chaperone 1-deoxygalactonojirimycin reduces tissue globotriaosylceramide levels in a mouse model of Fabry disease","volume":"18","author":"Khanna","year":"2010","journal-title":"Molecular Therapy"},{"issue":"11","key":"10.1016\/bs.apcsb.2018.09.004_bb0555","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/ajmg.a.37846","article-title":"Atypical presentation of infantile-onset Farber disease with novel ASAH1 mutations","volume":"170","author":"Kim","year":"2016","journal-title":"American Journal of Medical Genetics Part A"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb0560","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/art.21668","article-title":"Sphingosine 1-phosphate\/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: Regulation of synovial proliferation and inflammatory gene expression","volume":"54","author":"Kitano","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb0565","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","article-title":"The sphingolipid salvage pathway in ceramide metabolism and signaling","volume":"20","author":"Kitatani","year":"2008","journal-title":"Cellular Signalling"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0570","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7602526","article-title":"Sphingolipids in inflammation: From bench to bedside","volume":"2016","author":"Kitatani","year":"2016","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0575","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12917-016-0691-y","article-title":"In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses","volume":"12","author":"Kohyama","year":"2016","journal-title":"BMC Veterinary Research"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb0580","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.chemphyslip.2011.04.013","article-title":"A view on sphingolipids and disease","volume":"164","author":"Kolter","year":"2011","journal-title":"Chemistry and Physics of Lipids"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0585","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.cellbio.21.122303.120013","article-title":"Principles of lysosomal membrane digestion: Stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids","volume":"21","author":"Kolter","year":"2005","journal-title":"Annual Review of Cell and Developmental Biology"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.09.004_bb0590","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.bbamem.2006.05.027","article-title":"Sphingolipid metabolism diseases","volume":"1758","author":"Kolter","year":"2006","journal-title":"Biochimica et Biophysica Acta"},{"issue":"9","key":"10.1016\/bs.apcsb.2018.09.004_bb0595","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.febslet.2009.10.021","article-title":"Lysosomal degradation of membrane lipids","volume":"584","author":"Kolter","year":"2010","journal-title":"FEBS Letters"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb0600","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.mehy.2014.08.025","article-title":"Mutations in Niemann Pick type C gene are risk factor for Alzheimer's disease","volume":"83","author":"Kresojevi\u0107","year":"2014","journal-title":"Medical Hypotheses"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0605","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biochi.2016.09.011","article-title":"Alterations in membrane trafficking and pathophysiological implications in lysosomal storage disorders","volume":"130","author":"Kuech","year":"2016","journal-title":"Biochimie"},{"issue":"17","key":"10.1016\/bs.apcsb.2018.09.004_bb0610","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1007\/s00018-007-7076-0","article-title":"The metabolism and function of sphingolipids and glycosphingolipids","volume":"64","author":"Lahiri","year":"2007","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"2, Supplement 2","key":"10.1016\/bs.apcsb.2018.09.004_bb0615","doi-asserted-by":"crossref","first-page":"S364","DOI":"10.1016\/j.jaci.2007.06.016","article-title":"1. Lymphocytes","volume":"121","author":"LaRosa","year":"2008","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0620","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.it.2015.02.009","article-title":"Senescence-associated inflammatory responses: Aging and cancer perspectives","volume":"36","author":"Lasry","year":"2015","journal-title":"Trends in Immunology"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0625","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejmech.2014.04.061","article-title":"Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E2 synthase-1 enzyme (mPGES-1)","volume":"80","author":"Lauro","year":"2014","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0630","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1021\/acs.bioconjchem.7b00008","article-title":"Tocilizumab\u2013alendronate conjugate for treatment of rheumatoid arthritis","volume":"28","author":"Lee","year":"2017","journal-title":"Bioconjugate Chemistry"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.09.004_bb0635","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nm.2250","article-title":"Stat3-induced S1PR1 expression is critical for persistent Stat3 activation in tumors","volume":"16","author":"Lee","year":"2010","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0640","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5501\/wjv.v4.i2.42","article-title":"New advances on glial activation in health and disease","volume":"4","author":"Lee","year":"2015","journal-title":"World Journal of Virology"},{"issue":"16","key":"10.1016\/bs.apcsb.2018.09.004_bb0645","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1523\/JNEUROSCI.6383-09.2010","article-title":"Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones","volume":"30","author":"Lee","year":"2010","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0650","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.phrs.2014.01.005","article-title":"Pharmacological chaperoning: A primer on mechanism and pharmacology","volume":"83","author":"Leidenheimer","year":"2014","journal-title":"Pharmacological Research"},{"issue":"8","key":"10.1016\/bs.apcsb.2018.09.004_bb0655","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1194\/jlr.R057588","article-title":"Cytosolic phospholipase A2: Physiological function and role in disease","volume":"56","author":"Leslie","year":"2015","journal-title":"Journal of Lipid Research"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0660","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/geno.1999.5940","article-title":"The human acid ceramidase gene (ASAH): Structure, chromosomal location, mutation analysis, and expression","volume":"62","author":"Li","year":"1999","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0665","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nchembio850","article-title":"Structure of acid \u03b2-glucosidase with pharmacological chaperone provides insight into Gaucher disease","volume":"3","author":"Lieberman","year":"2006","journal-title":"Nature Chemical Biology"},{"issue":"8","key":"10.1016\/bs.apcsb.2018.09.004_bb0670","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104763","article-title":"GBA2-encoded \u03b2-glucosidase activity is involved in the inflammatory response to Pseudomonas aeruginosa","volume":"9","author":"Loberto","year":"2014","journal-title":"PLoS One"},{"issue":"130","key":"10.1016\/bs.apcsb.2018.09.004_bb0675","article-title":"Proinflammatory and immunoregulatory roles of eicosanoids in T cells","volume":"4","author":"Lone","year":"2013","journal-title":"Frontiers in Immunology"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb0680","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ajh.24352","article-title":"Reduction in C-reactive protein indicates successful targeting of the IL-1\/IL-6 axis resulting in improved survival in early stage multiple myeloma","volume":"91","author":"Lust","year":"2016","journal-title":"American Journal of Hematology"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2013.10.004","article-title":"Neuroinflammation: The role and consequences","volume":"79","author":"Lyman","year":"2014","journal-title":"Neuroscience Research"},{"issue":"7503","key":"10.1016\/bs.apcsb.2018.09.004_bb0690","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0695","series-title":"version 10.4","author":"Maestro","year":"2015"},{"issue":"16","key":"10.1016\/bs.apcsb.2018.09.004_bb0700","doi-asserted-by":"crossref","first-page":"11144","DOI":"10.1016\/S0021-9258(19)49887-6","article-title":"Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase, and sphinganine N-acyltransferase in mouse liver","volume":"267","author":"Mandon","year":"1992","journal-title":"Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/bs.apcsb.2018.09.004_bb0705","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/jnr.23751","article-title":"Beyond Krabbe's disease: The potential contribution of GALC deficiency to neuronal vulnerability in late onset synucleinopathies","volume":"94","author":"Marshall","year":"2016","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0710","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-med-050715-104432","article-title":"Lysosomal proteins as a therapeutic target in neurodegeneration","volume":"68","author":"Mc Donald","year":"2017","journal-title":"Annual Review of Medicine"},{"issue":"10","key":"10.1016\/bs.apcsb.2018.09.004_bb0715","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.2337\/db11-1433","article-title":"Attenuated Pik3r1 expression prevents insulin resistance and adipose tissue macrophage accumulation in diet-induced obese mice","volume":"61","author":"McCurdy","year":"2012","journal-title":"Diabetes"},{"issue":"Suppl. 2","key":"10.1016\/bs.apcsb.2018.09.004_bb0720","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00415-014-7386-8","article-title":"Genetic and laboratory diagnostic approach in Niemann Pick disease type C","volume":"261","author":"McKay Bounford","year":"2014","journal-title":"Journal of Neurology"},{"issue":"7203","key":"10.1016\/bs.apcsb.2018.09.004_bb0725","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb0730","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2010.03.006","article-title":"Inflammation 2010: New adventures of an old flame","volume":"140","author":"Medzhitov","year":"2010","journal-title":"Cell"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb0735","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1212\/WNL.0b013e3181ebdd64","article-title":"Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis","volume":"75","author":"Mehling","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb0740","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0745","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1006\/taap.1996.8029","article-title":"Sphingolipids\u2014The enigmatic lipid class: Biochemistry, physiology and pathophysiology","volume":"142","author":"Merrill","year":"1997","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"19","key":"10.1016\/bs.apcsb.2018.09.004_bb0750","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1016\/j.febslet.2006.07.035","article-title":"Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice","volume":"580","author":"Michaud","year":"2006","journal-title":"FEBS Letters"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0755","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cyto.2011.09.029","article-title":"Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican American: A cross-sectional study","volume":"57","author":"Mirza","year":"2012","journal-title":"Cytokine"},{"issue":"1\u20132","key":"10.1016\/bs.apcsb.2018.09.004_bb0760","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2016.11.006","article-title":"Gaucher disease: Progress and ongoing challenges","volume":"120","author":"Mistry","year":"2017","journal-title":"Molecular Genetics and Metabolism"},{"issue":"9","key":"10.1016\/bs.apcsb.2018.09.004_bb0765","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.febslet.2012.03.032","article-title":"Ceramide kinase deficiency improves diet-induced obesity and insulin resistance","volume":"586","author":"Mitsutake","year":"2012","journal-title":"FEBS Letters"},{"issue":"448","key":"10.1016\/bs.apcsb.2018.09.004_bb0770","article-title":"Pharmaceutical chaperones and proteostasis regulators in the therapy of lysosomal storage disorders: Current perspective and future promises","volume":"8","author":"Mohamed","year":"2017","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0775","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcmd.2015.05.009","article-title":"Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: Implication for bone pathology","volume":"55","author":"Mucci","year":"2015","journal-title":"Blood Cells, Molecules, and Diseases"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0780","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gene.2013.09.072","article-title":"Uncoupling of osteoblast\u2013osteoclast regulation in a chemical murine model of Gaucher disease","volume":"532","author":"Mucci","year":"2013","journal-title":"Gene"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0785","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/OARRR.S32582","article-title":"Long-term treatment of rheumatoid arthritis with adalimumab","volume":"5","author":"Murdaca","year":"2013","journal-title":"Open Access Rheumatology: Research and Reviews"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb0790","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1254\/jphs.13R18CP","article-title":"Role of sphingolipids in arachidonic acid metabolism","volume":"124","author":"Nakamura","year":"2014","journal-title":"Journal of Pharmacological Sciences"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0795","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/icb.2016.126","article-title":"Targeting cancer-related inflammation in the era of immunotherapy","volume":"95","author":"Nakamura","year":"2017","journal-title":"Immunology and Cell Biology"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0800","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10245332.2016.1240391","article-title":"Gaucher disease epidemiology and natural history: A comprehensive review of the literature","volume":"22","author":"Nalysnyk","year":"2017","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb0805","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/acn3.292","article-title":"Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study","volume":"3","author":"Narita","year":"2016","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0810","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/clpt.2012.193","article-title":"Senescent cells: A novel therapeutic target for aging and age-related diseases","volume":"93","author":"Naylor","year":"2012","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0815","series-title":"Lehninger principles of biochemistry","article-title":"Lipid biosynthesis","author":"Nelson","year":"2013"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb0820","doi-asserted-by":"crossref","first-page":"F209","DOI":"10.1136\/fn.88.3.F209","article-title":"Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections","volume":"88","author":"Ng","year":"2003","journal-title":"Archives of Disease in Childhood Fetal and Neonatal Edition"},{"issue":"10114","key":"10.1016\/bs.apcsb.2018.09.004_bb0825","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0830","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.molmed.2017.02.002","article-title":"Sphingosine-1-phosphate signaling in inflammatory bowel disease","volume":"23","author":"Nielsen","year":"2017","journal-title":"Trends in Molecular Medicine"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0835","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1476-5381.2009.00281.x","article-title":"Sphingolipids in inflammation: Pathological implications and potential therapeutic targets","volume":"158","author":"Nixon","year":"2009","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0840","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb0845","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.chembiol.2013.02.009","article-title":"Discovery of oxysterol-derived pharmacological chaperones for NPC1: Implication for the existence of second sterol-binding site","volume":"20","author":"Ohgane","year":"2013","journal-title":"Chemistry & Biology"},{"issue":"15","key":"10.1016\/bs.apcsb.2018.09.004_bb0850","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1016\/j.bmcl.2014.05.064","article-title":"Structure\u2013activity relationships of oxysterol-derived pharmacological chaperones for Niemann\u2013Pick type C1 protein","volume":"24","author":"Ohgane","year":"2014","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"17","key":"10.1016\/bs.apcsb.2018.09.004_bb0855","doi-asserted-by":"crossref","first-page":"R733","DOI":"10.1016\/j.cub.2012.07.029","article-title":"Evolution of inflammatory diseases","volume":"22","author":"Okin","year":"2012","journal-title":"Current Biology: CB"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0860","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1179\/016164108X323762","article-title":"Identification of two novel arylsulfatase A mutations with a polymorphism as a cause of metachromatic leukodystrophy","volume":"31","author":"\u00d6nder","year":"2009","journal-title":"Neurological Research"},{"issue":"Database issue","key":"10.1016\/bs.apcsb.2018.09.004_bb0865","doi-asserted-by":"crossref","first-page":"D358","DOI":"10.1093\/nar\/gkt1115","article-title":"The MIntAct project\u2014IntAct as a common curation platform for 11 molecular interaction databases","volume":"42","author":"Orchard","year":"2014","journal-title":"Nucleic Acids Research"},{"issue":"49","key":"10.1016\/bs.apcsb.2018.09.004_bb0870","doi-asserted-by":"crossref","first-page":"10647","DOI":"10.1021\/bi201619z","article-title":"Binding of 3,4,5,6-tetrahydroxyazepanes to the acid-\u03b2-glucosidase active site: Implications for pharmacological chaperone design for Gaucher disease","volume":"50","author":"Orwig","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0875","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4419-6741-1_13","article-title":"Cancer treatment strategies targeting sphingolipid metabolism","volume":"668","author":"Oskouian","year":"2010","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"21","key":"10.1016\/bs.apcsb.2018.09.004_bb0880","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1242\/jcs.169342","article-title":"Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling","volume":"128","author":"O\u2019Sullivan","year":"2015","journal-title":"Journal of Cell Science"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0885","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5582\/irdr.2016.01085","article-title":"Metachromatic leukodystrophy: Biochemical characterization of two (p.307Glu\u2192Lys, p.318Trp\u2192Cys) arylsulfatase A mutations","volume":"5","author":"\u00d6zkan","year":"2016","journal-title":"Intractable & Rare Diseases Research"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0890","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/humu.1380050216","article-title":"Donor splice site mutation in intron 5 of the HEXA gene in a Turkish infant with Tay-Sachs disease","volume":"5","author":"Ozkara","year":"1995","journal-title":"Human Mutation"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb0895","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1006\/mgme.1998.2742","article-title":"At least six different mutations in HEXA gene cause Tay-Sachs disease among the Turkish population","volume":"65","author":"Ozkara","year":"1998","journal-title":"Molecular Genetics and Metabolism"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb0900","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0387-7604(02)00219-X","article-title":"A new point mutation (G412 to A) at the last nucleotide of exon 3 of hexosaminidase \u03b1-subunit gene affects splicing","volume":"25","author":"Ozkara","year":"2003","journal-title":"Brain and Development"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb0905","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0387-7604(02)00213-9","article-title":"Characterization of two Turkish \u03b2-hexosaminidase mutations causing Tay-Sachs disease","volume":"25","author":"Ozkara","year":"2003","journal-title":"Brain and Development"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb0910","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.braindev.2003.09.006","article-title":"Sphingolipidoses in Turkey","volume":"26","author":"Ozkara","year":"2004","journal-title":"Brain and Development"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.09.004_bb0915","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0387-7604(97)00061-2","article-title":"Sandhoff disease in the Turkish population","volume":"19","author":"Ozkara","year":"1997","journal-title":"Brain and Development"},{"issue":"7643","key":"10.1016\/bs.apcsb.2018.09.004_bb0920","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0925","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2013.09.002","article-title":"Gaucher disease: Chemotactic factors and immunological cell invasion in a mouse model","volume":"111","author":"Pandey","year":"2014","journal-title":"Molecular Genetics and Metabolism"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb0930","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/emmm.200900036","article-title":"Treating lysosomal storage diseases with pharmacological chaperones: From concept to clinics","volume":"1","author":"Parenti","year":"2009","journal-title":"EMBO Molecular Medicine"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.09.004_bb0935","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/mt.2015.62","article-title":"Pharmacological chaperone therapy: Preclinical development, clinical translation, and prospects for the treatment of lysosomal storage disorders","volume":"23","author":"Parenti","year":"2015","journal-title":"Molecular Therapy"},{"issue":"9","key":"10.1016\/bs.apcsb.2018.09.004_bb0940","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4155\/fmc.14.40","article-title":"Pharmacological chaperone therapy for lysosomal storage diseases","volume":"6","author":"Parenti","year":"2014","journal-title":"Future Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0945","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/ijmm.2012.1187","article-title":"New strategies for the treatment of lysosomal storage diseases (review)","volume":"31","author":"Parenti","year":"2013","journal-title":"International Journal of Molecular Medicine"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb0950","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bbalip.2013.08.019","article-title":"Ceramide synthases as potential targets for therapeutic intervention in human diseases","volume":"1841","author":"Park","year":"2014","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb0955","first-page":"729","article-title":"Developing therapeutic approaches for metachromatic leukodystrophy","volume":"7","author":"Patil","year":"2013","journal-title":"Drug Design, Development and Therapy"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.09.004_bb0960","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1021\/jm300063b","article-title":"Discovery, structure\u2013activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase","volume":"55","author":"Patnaik","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0965","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.plipres.2010.10.003","article-title":"Sphingolipids and expression regulation of genes in cancer","volume":"50","author":"Patwardhan","year":"2011","journal-title":"Progress in Lipid Research"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb0970","first-page":"e949","article-title":"Krabbe disease: Report of a rare lipid storage and neurodegenerative disorder","volume":"9","author":"Pavuluri","year":"2017","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/bs.apcsb.2018.09.004_bb0975","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.bbadis.2011.06.003","article-title":"Niemann-Pick type C1 deficiency in microglia does not cause neuron death in vitro","volume":"1812","author":"Peake","year":"2011","journal-title":"Biochimica et Biophysica Acta"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb0980","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/med.21424","article-title":"Nonsteroidal anti-inflammatory therapy: A journey toward safety","volume":"37","author":"Pereira-Leite","year":"2016","journal-title":"Medicinal Research Reviews"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.09.004_bb0985","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1039\/C7SC04712F","article-title":"Tuning protein folding in lysosomal storage diseases: The chemistry behind pharmacological chaperones","volume":"9","author":"Pereira","year":"2018","journal-title":"Chemical Science"},{"issue":"7503","key":"10.1016\/bs.apcsb.2018.09.004_bb0990","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature13476","article-title":"Sphingolipid lysosomal storage disorders","volume":"510","author":"Platt","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb0995","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrd.2017.214","article-title":"Emptying the stores: Lysosomal diseases and therapeutic strategies","volume":"17","author":"Platt","year":"2018","journal-title":"Nature Reviews Drug Discovery"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb1000","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.molmed.2016.12.003","article-title":"Mitochondrial dysfunction and neurodegeneration in lysosomal storage disorders","volume":"23","author":"Plotegher","year":"2017","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2017.12.022","article-title":"Autoimmunity in multiple sclerosis: Role of sphingolipids, invariant NKT cells and other immune elements in control of inflammation and neurodegeneration","volume":"385","author":"Podbielska","year":"2018","journal-title":"Journal of the Neurological Sciences"},{"issue":"Suppl. 2","key":"10.1016\/bs.apcsb.2018.09.004_bb1010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/2047-783X-15-S2-120","article-title":"Proinflammatory cytokines IL-6 and TNF-\u03b1 and the development of inflammation in obese subjects","volume":"15","author":"Popko","year":"2010","journal-title":"European Journal of Medical Research"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb1015","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/mt.2009.53","article-title":"The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts","volume":"17","author":"Porto","year":"2009","journal-title":"Molecular Therapy"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.09.004_bb1020","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1038\/mt.2012.152","article-title":"Pharmacological enhancement of \u03b1-glucosidase by the allosteric chaperone N-acetylcysteine","volume":"20","author":"Porto","year":"2012","journal-title":"Molecular Therapy"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb1025","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10545-011-9424-3","article-title":"Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and the human recombinant alpha-galactosidase A in cultured fibroblasts from patients with Fabry disease","volume":"35","author":"Porto","year":"2012","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb1030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bbalip.2016.02.007","article-title":"Regulation of cell migration and inflammation by ceramide 1-phosphate","volume":"1861","author":"Presa","year":"2016","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.prostaglandins.2017.03.006","article-title":"Novel sphingosine kinase-1 inhibitor, LCL351, reduces immune responses in murine DSS-induced colitis","volume":"130","author":"Pulkoski-Gross","year":"2017","journal-title":"Prostaglandins & Other Lipid Mediators"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb1040","first-page":"1","article-title":"The conflicting role of Rac1 in inflammation","volume":"2","author":"Qin","year":"2015","journal-title":"Inflammation and Cell Signaling"},{"issue":"19","key":"10.1016\/bs.apcsb.2018.09.004_bb1045","doi-asserted-by":"crossref","first-page":"14134","DOI":"10.1074\/jbc.M109.076810","article-title":"Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: Significance for apoptosis and multiple sclerosis","volume":"285","author":"Qin","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.09.004_bb1050","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1517\/13543776.18.7.723","article-title":"The development of novel therapies for rheumatoid arthritis","volume":"18","author":"Quan","year":"2008","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1055","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/480739","article-title":"Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain","volume":"2013","author":"Ramesh","year":"2013","journal-title":"Mediators of Inflammation"},{"issue":"Suppl. 1","key":"10.1016\/bs.apcsb.2018.09.004_bb1060","first-page":"663","article-title":"The GM1 and GM2 gangliosidoses: Natural history and progress toward therapy","volume":"13","author":"Regier","year":"2016","journal-title":"Pediatric Endocrinology Reviews"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb1065","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.cellsig.2008.10.011","article-title":"Inflammatory signaling and cellular senescence","volume":"21","author":"Ren","year":"2009","journal-title":"Cellular Signalling"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb1070","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb1075","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s13311-014-0294-x","article-title":"A GCase chaperone improves motor function in a mouse model of synucleinopathy","volume":"11","author":"Richter","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2017.07.004","article-title":"Overview of immune abnormalities in lysosomal storage disorders","volume":"188","author":"Rigante","year":"2017","journal-title":"Immunology Letters"},{"issue":"9","key":"10.1016\/bs.apcsb.2018.09.004_bb1085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/jbiol186","article-title":"Q&A: What are pharmacological chaperones and why are they interesting?","volume":"8","author":"Ringe","year":"2009","journal-title":"Journal of Biology"},{"issue":"10","key":"10.1016\/bs.apcsb.2018.09.004_bb1090","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2400","article-title":"The alliance of sphingosine-1-phosphate and its receptors in immunity","volume":"8","author":"Rivera","year":"2008","journal-title":"Nature Reviews Immunology"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb1095","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1124\/jpet.111.179168","article-title":"Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo","volume":"337","author":"Roviezzo","year":"2011","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"43","key":"10.1016\/bs.apcsb.2018.09.004_bb1100","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1038\/onc.2012.640","article-title":"Senescence and aging: The critical roles of p53","volume":"32","author":"Rufini","year":"2013","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/bs.apcsb.2018.09.004_bb1105","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1177\/08830738050200100901","article-title":"Krabbe disease: Severe neonatal presentation with a family history of multiple sclerosis","volume":"20","author":"Sahai","year":"2005","journal-title":"Journal of Child Neurology"},{"issue":"32","key":"10.1016\/bs.apcsb.2018.09.004_bb1110","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1039\/C6CC01564F","article-title":"Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: Lessons from Gaucher, GM1-gangliosidosis and Fabry diseases","volume":"52","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2016","journal-title":"Chemical Communications"},{"issue":"18","key":"10.1016\/bs.apcsb.2018.09.004_bb1115","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMoa1513248","article-title":"Ozanimod induction and maintenance treatment for ulcerative colitis","volume":"374","author":"Sandborn","year":"2016","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.09.004_bb1120","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/emmm.201302781","article-title":"Farber disease: Understanding a fatal childhood disorder and dissecting ceramide biology","volume":"5","author":"Sands","year":"2013","journal-title":"EMBO Molecular Medicine"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.chemphyslip.2015.07.007","article-title":"Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase)","volume":"197","author":"Sanlleh\u00ed","year":"2016","journal-title":"Chemistry and Physics of Lipids"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pneurobio.2014.12.001","article-title":"Gaucher-related synucleinopathies: The examination of sporadic neurodegeneration from a rare (disease) angle","volume":"125","author":"Sardi","year":"2015","journal-title":"Progress in Neurobiology"},{"issue":"Part A","key":"10.1016\/bs.apcsb.2018.09.004_bb1135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mcn.2015.03.013","article-title":"Glucocerebrosidase and Parkinson disease: Recent advances","volume":"66","author":"Schapira","year":"2015","journal-title":"Molecular and Cellular Neuroscience"},{"issue":"1\u20132","key":"10.1016\/bs.apcsb.2018.09.004_bb1140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2016.12.008","article-title":"Types A and B Niemann-Pick disease","volume":"120","author":"Schuchman","year":"2017","journal-title":"Molecular Genetics and Metabolism"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb1145","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/1673-5374.228712","article-title":"Heterozygous carriers of galactocerebrosidase mutations that cause Krabbe disease have impaired microglial function and defective repair of myelin damage","volume":"13","author":"Scott-Hewitt","year":"2018","journal-title":"Neural Regeneration Research"},{"issue":"15","key":"10.1016\/bs.apcsb.2018.09.004_bb1150","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/hmg\/ddx153","article-title":"Heterozygote galactocerebrosidase (GALC) mutants have reduced remyelination and impaired myelin debris clearance following demyelinating injury","volume":"26","author":"Scott-Hewitt","year":"2017","journal-title":"Human Molecular Genetics"},{"issue":"381","key":"10.1016\/bs.apcsb.2018.09.004_bb1155","article-title":"Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation","volume":"8","author":"Selvam","year":"2015","journal-title":"Science Signaling"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb1160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.advenzreg.2009.10.024","article-title":"Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function","volume":"50","author":"Serra","year":"2010","journal-title":"Advances in Enzyme Regulation"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb1165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejmhg.2016.02.001","article-title":"Treatment options for patients with Gaucher disease","volume":"17","author":"Shawky","year":"2016","journal-title":"Egyptian Journal of Medical Human Genetics"},{"issue":"9","key":"10.1016\/bs.apcsb.2018.09.004_bb1170","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ni.2066","article-title":"The kinase IKK\u03b1 inhibits activation of the transcription factor NF-\u03baB by phosphorylating the regulatory molecule TAX1BP1","volume":"12","author":"Shembade","year":"2011","journal-title":"Nature Immunology"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb1175","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bbrc.2008.02.125","article-title":"Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase","volume":"369","author":"Shen","year":"2008","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/8904_2013_244","article-title":"Burden of lysosomal storage disorders in India: Experience of 387 affected children from a single diagnostic facility","volume":"12","author":"Sheth","year":"2014","journal-title":"JIMD Reports"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb1185","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1039\/C6MB00866F","article-title":"Screening methods for identifying pharmacological chaperones","volume":"13","author":"Shin","year":"2017","journal-title":"Molecular BioSystems"},{"issue":"11","key":"10.1016\/bs.apcsb.2018.09.004_bb1190","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"The Lancet. Neurology"},{"issue":"7463","key":"10.1016\/bs.apcsb.2018.09.004_bb1195","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature12332","article-title":"Non-vesicular trafficking by a ceramide-1-phosphate transfer protein regulates eicosanoids","volume":"500","author":"Simanshu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2326409816650465","article-title":"Lysosomes, lysosomal storage diseases, and inflammation","volume":"4","author":"Simonaro","year":"2016","journal-title":"Journal of Inborn Errors of Metabolism and Screening"},{"issue":"11","key":"10.1016\/bs.apcsb.2018.09.004_bb1205","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ng1460","article-title":"Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase","volume":"36","author":"Simpson","year":"2004","journal-title":"Nature Genetics"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb1210","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/annrheumdis-2011-200395","article-title":"Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: Disassociation of the link between inflammation and destruction","volume":"71","author":"Smolen","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb1215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1096\/fj.08-118109","article-title":"A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis","volume":"23","author":"Snider","year":"2009","journal-title":"The FASEB Journal"},{"issue":"Suppl. 1","key":"10.1016\/bs.apcsb.2018.09.004_bb1220","article-title":"Polyarticular arthritis as presenting feature of Farber disease: A lysosomal storage disease involving inflammation","volume":"12","author":"S\u00f3lyom","year":"2014","journal-title":"Pediatric Rheumatology Online Journal"},{"issue":"11","key":"10.1016\/bs.apcsb.2018.09.004_bb1225","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/jnr.23762","article-title":"New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones","volume":"94","author":"Spratley","year":"2016","journal-title":"Journal of Neuroscience Research"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.09.004_bb1230","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/mt.2015.69","article-title":"Anti-inflammatory therapy with simvastatin improves neuroinflammation and CNS function in a mouse model of metachromatic leukodystrophy","volume":"23","author":"Stein","year":"2015","journal-title":"Molecular Therapy"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb1235","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb1240","first-page":"469","article-title":"Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: The fat's in the fire","volume":"4","author":"Suh","year":"2015","journal-title":"Translational Cancer Research"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb1245","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/ijms19020420","article-title":"Expansion of sphingosine kinase and sphingosine-1-phosphate receptor function in normal and cancer cells: From membrane restructuring to mediation of estrogen signaling and stem cell programming","volume":"19","author":"Sukocheva","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1250","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/490804","article-title":"Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis","volume":"2012","author":"Sultani","year":"2012","journal-title":"Chemotherapy Research and Practice"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb1255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2183\/pjab.90.145","article-title":"Emerging novel concept of chaperone therapies for protein misfolding diseases","volume":"90","author":"Suzuki","year":"2014","journal-title":"Proceedings of the Japan Academy. Series B, Physical and Biological Sciences"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1260","series-title":"Advances in protein chemistry and structural biology","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/bs.apcsb.2015.10.001","article-title":"Personalized pharmacoperones for lysosomal storage disorder: Approach for next-generation treatment","volume":"Vol. 102","author":"Syed Haneef","year":"2016"},{"issue":"Database issue","key":"10.1016\/bs.apcsb.2018.09.004_bb1265","doi-asserted-by":"crossref","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: Quality-controlled protein-protein association networks, made broadly accessible","volume":"45","author":"Szklarczyk","year":"2017","journal-title":"Nucleic Acids Research"},{"issue":"6116","key":"10.1016\/bs.apcsb.2018.09.004_bb1270","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1126\/science.1230720","article-title":"Anti-inflammatory therapy in chronic disease: Challenges and opportunities","volume":"339","author":"Tabas","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb1275","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/mt.2012.263","article-title":"A bicyclic 1-deoxygalactonojirimycin derivative as a novel pharmacological chaperone for GM1 gangliosidosis","volume":"21","author":"Takai","year":"2013","journal-title":"Molecular Therapy"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb1280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2012.01.103","article-title":"Sphingosine 1-phosphate (S1P)\/S1P receptor 1 signaling regulates receptor activator of NF-\u03baB ligand (RANKL) expression in rheumatoid arthritis","volume":"419","author":"Takeshita","year":"2012","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1285","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jare.2017.11.004","article-title":"Arachidonic acid: Physiological roles and potential health benefits\u2014A review","volume":"11","author":"Tallima","year":"2018","journal-title":"Journal of Advanced Research"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1290","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.2147\/IJN.S101285","article-title":"Upregulation of Akt\/Nf-\u03baB-regulated inflammation and Akt\/Bad-related apoptosis signaling pathway involved in hepatic carcinoma process: Suppression by carnosic acid nanoparticle","volume":"11","author":"Tang","year":"2016","journal-title":"International Journal of Nanomedicine"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb1295","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1152\/physrev.00029.2016","article-title":"Pharmacoperones as novel therapeutics for diverse protein conformational diseases","volume":"98","author":"Tao","year":"2018","journal-title":"Physiological Reviews"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb1300","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nm1748","article-title":"Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis","volume":"14","author":"Teichgr\u00e4ber","year":"2008","journal-title":"Nature Medicine"},{"issue":"3\u20134","key":"10.1016\/bs.apcsb.2018.09.004_bb1305","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0300-9084(03)00047-6","article-title":"Salvage pathways in glycosphingolipid metabolism","volume":"85","author":"Tettamanti","year":"2003","journal-title":"Biochimie"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1310","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.carres.2016.03.020","article-title":"Synthesis of C-5a-substituted derivatives of 4-epi-isofagomine: Notable \u03b2-galactosidase inhibitors and activity promotors of GM1-gangliosidosis related human lysosomal \u03b2-galactosidase mutant R201C","volume":"429","author":"Thonhofer","year":"2016","journal-title":"Carbohydrate Research"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.09.004_bb1315","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI97949","article-title":"Role of sphingolipids in senescence: Implication in aging and age-related diseases","volume":"128","author":"Trayssac","year":"2018","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb1320","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clim.2010.03.428","article-title":"Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model","volume":"136","author":"Tsunemi","year":"2010","journal-title":"Clinical Immunology"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1325","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-12-398314-5.00004-0","article-title":"Inflammation in Parkinson's disease","volume":"88","author":"Tufekci","year":"2012","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"issue":"11","key":"10.1016\/bs.apcsb.2018.09.004_bb1330","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochimica et Biophysica Acta"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb1335","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/adt.2011.0370","article-title":"Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders","volume":"9","author":"Valenzano","year":"2011","journal-title":"Assay and Drug Development Technologies"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb1340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2013-101857","article-title":"A systematic review on screening for Fabry disease: Prevalence of individuals with genetic variants of unknown significance","volume":"51","author":"van der Tol","year":"2014","journal-title":"Journal of Medical Genetics"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.09.004_bb1345","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/glia.21021","article-title":"Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions","volume":"58","author":"Van Doorn","year":"2010","journal-title":"Glia"},{"issue":"16","key":"10.1016\/bs.apcsb.2018.09.004_bb1350","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1517\/14656566.2012.729039","article-title":"Treatment options for lysosomal storage disorders: Developing insights","volume":"13","author":"van Gelder","year":"2012","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb1355","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.beem.2014.10.001","article-title":"Metachromatic leukodystrophy: Disease spectrum and approaches for treatment","volume":"29","author":"van Rappard","year":"2015","journal-title":"Best Practice & Research Clinical Endocrinology & Metabolism"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb1360","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.mad.2006.01.003","article-title":"Shift in sphingolipid metabolism leads to an accumulation of ceramide in senescence","volume":"127","author":"Venable","year":"2006","journal-title":"Mechanisms of Ageing and Development"},{"issue":"6\u20137","key":"10.1016\/bs.apcsb.2018.09.004_bb1365","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1515\/hsz-2014-0301","article-title":"Innate immune responses in the brain of sphingolipid lysosomal storage diseases","volume":"396","author":"Vitner","year":"2015","journal-title":"Biological Chemistry"},{"issue":"20","key":"10.1016\/bs.apcsb.2018.09.004_bb1370","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.97.20.10954","article-title":"Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation","volume":"97","author":"Wada","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.09.004_bb1375","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb1380","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson's disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Translational Neurodegeneration"},{"issue":"235","key":"10.1016\/bs.apcsb.2018.09.004_bb1385","article-title":"Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia","volume":"16","author":"W\u0105tek","year":"2017","journal-title":"Lipids in Health and Disease"},{"issue":"11","key":"10.1016\/bs.apcsb.2018.09.004_bb1390","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1182\/blood.V110.11.2404.2404","article-title":"Pharmacological chaperone therapy for the treatment of Gaucher disease: Results of phase 1 clinical trials and a clinical ex vivo response study with a survey of blood markers for 53 Gaucher patients","volume":"110","author":"Weinreb","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.09.004_bb1395","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb1400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035787","article-title":"Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB","volume":"7","author":"Wilkinson","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.09.004_bb1405","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/ijms18040741","article-title":"Sphingosine-1-phosphate metabolism and its role in the development of inflammatory bowel disease","volume":"18","author":"Wollny","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.09.004_bb1410","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/mt.2015.87","article-title":"Coformulation of a novel human \u03b1-galactosidase A with the pharmacological chaperone AT1001 leads to improved substrate reduction in Fabry mice","volume":"23","author":"Xu","year":"2015","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.apcsb.2018.09.004_bb1415","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jmgm.2017.07.014","article-title":"Investigation of novel pharmacological chaperones for Gaucher disease","volume":"76","author":"Yilmazer","year":"2017","journal-title":"Journal of Molecular Graphics and Modelling"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb1420","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jre.12276","article-title":"Periodontal inflammation and alveolar bone loss induced by Aggregatibacter actinomycetemcomitans is attenuated in sphingosine kinase 1-deficient mice","volume":"51","author":"Yu","year":"2015","journal-title":"Journal of Periodontal Research"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.09.004_bb1425","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1021\/cb500143h","article-title":"Molecular basis of 1-deoxygalactonojirimycin arylthiourea binding to human \u03b1-galactosidase A: Pharmacological chaperoning efficacy on Fabry disease mutants","volume":"9","author":"Yu","year":"2014","journal-title":"ACS Chemical Biology"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.09.004_bb1430","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"International Anesthesiology Clinics"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.09.004_bb1435","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2012.05.001","article-title":"Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1","volume":"91","author":"Zhou","year":"2012","journal-title":"American Journal of Human Genetics"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Molecular Chaperones in Human Disorders"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162318300609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162318300609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T01:35:29Z","timestamp":1662514529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162318300609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":286,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2018.09.004","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}